Metabolomics in the field of Oncology / Cancer Metabolomics

Metabolomics cancer research is being used to discover diagnostic cancer biomarkers in the clinic and in a research institute, to a better understand its complex heterogeneous nature, to discover pathways which involved in cancer that could be used for new targets and to monitor metabolic biomarkers during therapeutic intervention. These metabolomics approaches may also provide evidence to personalized cancer treatments by providing useful information to the clinician about the cancer patient’s response to medical interventions. The ultimate aims of most metabolomics cancer studies are to discover cancer-specific diagnostic, prognostic or predictive biomarkers for a patient. Untargeted metabolomics is an important and excellent tool for probing cancer-altered biochemical pathways.

    Related Conference of Metabolomics in the field of Oncology / Cancer Metabolomics

    October 10-11, 2022

    International Conference on Biosimilars & Pharmaceuticals

    Amsterdam, Netherlands
    October 24-25, 2022

    5th International Conference on Glycobiology

    Paris, France
    October 27-28, 2022

    2nd Annual Summit on Advanced Bionics

    Rome, Italy
    November 14-15, 2022

    4th International Conference on Biochemistry

    London, UK
    November 14-15, 2022

    4th International Conference on Nucleic Acids

    London, UK
    February 22-23, 2023

    International Bio Summit and Expo

    London, UK
    April 17-18, 2023

    13th World Glycobiology Congress

    Rome, Italy
    October 30-31, 2023

    14th World Congress on Cell & Tissue Science

    Rome, Italy

    Metabolomics in the field of Oncology / Cancer Metabolomics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in